About this Episode
A vaccine already used around the world to prevent shingles may have an unexpected extra benefit: it could dramatically reduce the risk of serious heart problems.
Shingles — caused by reactivation of the varicella-zoster virus, the same virus behind chickenpox — is mainly known for causing painful rashes and nerve damage. But scientists have increasingly suspected that the infection might also trigger dangerous inflammation affecting the heart and blood vessels.
Now, a major long-term study suggests that getting vaccinated against shingles can do much more than prevent the illness itself. Researchers found that people who received the vaccine had about a 23% lower overall risk of cardiovascular events, including heart attacks and strokes.
Even more striking, the risk of certain heart-related complications dropped by as much as 40–50% in some groups of vaccinated individuals. The protective effect appeared to last for several years after vaccination, suggesting the immune response may reduce inflammation linked to cardiovascular disease.
Scientists believe the explanation is biological. Viral infections like shingles can trigger systemic inflammation and damage blood vessels. By preventing the infection in the first place, the vaccine may also prevent the chain reaction that leads to cardiovascular problems.
While more research is still needed to fully understand the mechanism, the findings point to something powerful: a preventive tool already widely available may also help reduce one of the world’s leading causes of death.
Sometimes the most exciting medical breakthroughs aren’t brand-new drugs — they’re new discoveries about tools we already have.
